PharmaShots | Incisive News in 3 Shots

Subscribe Now

chronic hepatitis c infection

Gilead's Epclusa (Sofosbuvir/Velpatasvir) Receives the US FDA's Approval for Children with Chronic Hepatitis C Infection

Gilead's Epclusa (Sofosbuvir/Velpatasvir) Receives the US FDA's Approval for Children with Chronic Hepatitis C Infection

June 11, 2021

Gilead's Vosevi (sofosbuvir- velpatasvir and voxilaprevir) Receives NMPA's Approval for Chronic Hepatitis C Infection Who Require Re-Treatment

Gilead's Vosevi (sofosbuvir- velpatasvir and voxilaprevir) Receives NMPA's Approval for Chronic Hepatitis C Infection Who Require...

December 23, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us